Thing

Uncompassionate use: the inconsistent offering of life-saving unlicensed medicines

Compassionate use schemes offered by pharmaceutical companies are struggling to live up to their name, as data from a third of acute trusts reveal an inequitable provision of medicines through schemes across England.…

Pharmacists in developing countries to be offered training as part of UK government package to tackle AMR

Funding of £210m from the UK government's aid budget will support 20,000 training sessions for pharmacists and other healthcare staff.…

Clinical placements can give pharmacy students a real-life lesson in health inequalities

Teaching staff at the University of Nottingham School of Pharmacy say their practical placement pilot for second-year MPharm students should be adopted more widely to promote a reduction in health inequalities.…

Do antihypertensive medicines increase the risk of depression?

A review of the evidence to examine whether exposure to antihypertensive medicines is linked with depression.…

Decision to fine liothyronine supplier millions of pounds for price hikes upheld at tribunal

Fines of £84.2m have been imposed on Advanz Pharma and two former owners after a tribunal upheld the Competition and Markets Authority’s judgement that they had breached competition law.…

NHS saved £78m on ‘low priority’ medicines in 2022/2023

NHS England had previously said a change in prescribing guidance could save ‘up to £141m’ annually.…

Second ADHD medication shortage leaves patients in ‘very difficult position’, pharmacists warn

A medicine supply notification warned that atomoxetine 40mg and 60mg capsules will be out of stock until September 2023…

Pharmacy teams told to ‘urgently’ order unlicensed imports of chemotherapy drugs in shortage warning

Exclusive: A ‘Tier 3 — high impact’ alert has been issued for the platinum-based chemotherapy agents cisplatin, carboplatin and oxaliplatin.…

Community pharmacy supervision does not mean overseeing ‘individual transactions’, pharmacy bodies determine

The cross-sector group of seven pharmacy sector organisations says public, primary and secondary legislation should be updated to reflect its supervision recommendations.…

Lest we forget lessons learned from the COVID-19 pandemic

The pick of the month’s academic papers from Parastou Donyai, chief scientist at the Royal Pharmaceutical Society.…